Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors.

A series of indazoles have been discovered as KHK inhibitors from a pyrazole hit identified through fragment based drug discovery. The lead compounds showed KHK enzyme activity in the nM range with amendable pharmaceutical properties.